Les Laboratoires Pierre Fabre étaient présents au Forum Santé du Futur 🚀 Nuria Perez Cullell, Directrice Médicale, Patient et Consommateur ainsi que Jimmy Le Digabel, Chargé de recherche et chef de projet clinique Biophysique, Biostatistiques et Technologies Numériques chez les Laboratoires Pierre Fabre, ont intervenus sur la table ronde « Les Données Artificielles : Quels Usages Pour Le Développement Thérapeutique ? ». Les données artificielles sont conçues pour reproduire les caractéristiques des données réelles 📈 et sont utilisées en recherche clinique pour compléter des cohortes, surtout pour les maladies rares ou en cas de recrutement insuffisant. L'évaluation et la validation de ces méthodes sont essentielles pour garantir la fiabilité des essais cliniques. 🤝 En collaboration avec Alia Santé, nous optimisons l'utilisation de ces données. 🎯 Mais l’avenir des essais cliniques doit rester centré sur le patient et l’implication des associations de patients est clé pour apporter une meilleure compréhension des produits et des pathologies ; tout comme l’intégration de données de vraie, cruciale pour le développement thérapeutique. Chez Pierre Fabre, nous sommes engagés à innover et à améliorer continuellement nos essais cliniques pour le bénéfice des patients 💙. Eurobiomed #PierreFabre #NewWaysToCare #Santé #Innovation
Pierre Fabre Laboratories
Pharmaceutical Manufacturing
Toulouse, Occitanie 408,598 followers
New ways to care
About us
Laboratoires Pierre Fabre held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise. This makes Pierre Fabre Group : 💊 A pharmaceutical group with a strong positioning : medical and natural 🥈 The second largest dermo-cosmetics laboratory in the world 🥈 The second largest private French pharmaceutical group 🥇 The market leader in France for products sold over the counter in pharmacies. Our portfolio includes several medical franchises and international brands including ; Pharmaceutical Care Pierre Fabre Oncologie Pierre Fabre Dermatologie Naturactive Eau Thermale Avène Klorane Ducray René Furterer A-Derma Pierre Fabre Oral Care Glytone (US) Darrow (Brasil) Established in the Occitanie region since its creation, we manufacture over 95% of our products in France. We keep innovating passionately with our teams in 2 innovation centers in Brasil and Japan as well as in 6 R&D centers in France. Thanks to our 9,600 employees in 44 subsidiaries and our distribution activities in 120 countries, our group generated €2.7 billion in revenues in 2022, 69% of which is from international business. Pierre Fabre Group has a unique company structure. 86% of the Pierre Fabre Group is held by the Pierre Fabre Foundation, a government-recognized public-interest foundation, while a smaller share is owned by its employees via an employee stock ownership plan. In 2020, the independent organization ECOCERT Environment awarded Pierre Fabre's CSR policy at "excellence" level : - Excellence being the highest maturity level of the ECOCERT 26000 standard.
- Website
-
https://www.pierre-fabre.com
External link for Pierre Fabre Laboratories
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001 employees
- Headquarters
- Toulouse, Occitanie
- Type
- Privately Held
- Founded
- 1962
- Specialties
- From Health to Beauty, Family Health, Dermo-Cosmetics, Pharmaceuticals, De la Santé à la Beauté, Dermo-Cosmétique, Médicaments, Santé Familiale, oncology, skincare, haircare, and personal care
Locations
Employees at Pierre Fabre Laboratories
Updates
-
🔬 With over 40 years of dedication to Oncology, Pierre Fabre Laboratories has been at the forefront of cancer care. Our holistic approach encompasses everything from prevention and treatment to support during and after treatment, guaranteeing to patients complete care at every stage. Specializing in melanoma, breast, colorectal, lung and hematological cancers, and pre-cancerous skin conditions, with a focus on precision medicine. Our goal is to bring clinically meaningful advancements to oncology patients thanks to partners like Scorpion Therapeutics, Atara Biotherapeutics, Vernalis, Foundation Medicine, Pfizer 🎯 At the heart of our mission are the patients. Their well-being and health drive us to innovate for new solutions and push the boundaries of what's possible in cancer care 💙 👉 Follow Pierre Fabre Oncology for more! #PierreFabre #NewWaysToCare #Oncology #Cancer #Innovation
-
#BreastAwarenessMonth: Take care of yourself, check yourself 🌸 Master the key steps of self-examination to early detect breast cancer. Your health, your priority! 💕 #PierreFabre #NewWaysToCare #BreastAwarenessMonth #BreastCancer #OurBreastJourney #SelfExamination
-
Unveiled earlier this year, the #PierreFabreNewGen is an internal “think tank” of international members, bringing its fresh perspectives to reshape our strategy 👥💡 Today, we are thrilled to introduce our first subsidiary declination of the New Gen: the NEXus Board pilot project in Belgium – a dynamic team that serves as the vital link that unites diverse departments, fostering seamless communication and strategic integration. Their mission? To break down silos, propel innovation, and shape the future of their local affiliate with over-arching projects. 🚀 Meet Colombine de Vivar, Max Decock, Imane Gamgami, Ellen Pieters and Laurens Jan van Driel M.D., the first generation of this initiative 🙌 We are excited to roll out this initiative in all other Pierre Fabre affiliates worldwide very soon! Together, we're not just embracing change, we're leading it 💙 #PierreFabre #NewWaysToCare #NEXusBoard #Innovation
-
This October, join Pierre Fabre Laboratories for #OurBreastJourney! Together, we'll explore practical tips, essential resources, and inspiring stories to raise breast cancer awareness. 🎗️ Stay tuned for more information and support throughout Breast Cancer Awareness Month. ➡️ https://bit.ly/4ejwJdt #PierreFabre #NewWaysToCare #BreastAwarenessMonth #BreastCancer
-
All patients with metastatic colorectal cancer (#mCRC) should have biomarker testing. Cancer biomarkers are changes and mutations in genes, DNA or proteins that are found in blood, tissue, or other body fluids and give your specialist and medical team valuable information about the characteristics of your tumor. Today, on World mCRC Day, Pierre Fabre Laboratories join the international advocacy community (Digestive Cancers Europe and Global Colon Cancer Association) to raise awareness of mCRC and importance of biomarkers, including their impact on mCRC treatment 🩺. 👉 Please visit www.knowyourbiomarker.org to learn more #PierreFabre #NewWaysToCare #worldmCRCDay #cancer #CRC #colorectalcancer
-
[Numbers that Matter] You are over 400 000 following us from all over the globe! This means that our #NewWaysToCare crosses borders and oceans, inspiring more and more researchers and healthcare professionals to improve patients lives everywhere. And so, we wanted to say: MERCI ! 🙏 Merci ! For caring for others. 🙏 Merci ! For supporting innovation in healthcare. 🙏 Merci ! For sharing our vision and message. As pioneers of care, let's keep innovating and pushing research forward, to constantly improve our solutions, and stay at the forefront of care. #NewWaysToCare #PierreFabre #Innovation #Healthcare
-
🏆 Pierre Fabre Laboratories has been recognized in the prestigious TIME and Statista World’s Best Companies ranking, and we couldn't be prouder of this achievement. It's a testament to the dedication and innovative spirit that thrives within our teams. Here is a snapshot of our rankings: 👉 20th among global Pharma companies 👉 7th among global Beauty companies 👉 55th among French companies 👉 2nd French pharma company 👉 3rd French beauty company 👉 386th on Employee Satisfaction worldwide These rankings reflect our commitment to excellence across various domains. They are based on three critical scores: employee satisfaction, sustainability transparency and revenue growth. Behind these numbers are the human innovators: our collaborators. They are the heart of Pierre Fabre, driving us forward with their passion, creativity, and expertise. Thank you to all our teams for their unwavering commitment and to our customers and partners for their trust and collaboration. Together, we're not just building a company; we're shaping a healthier, more sustainable future for all 💙 More here: https://lnkd.in/dFWdPvm5 #PierreFabre #NewWaysToCare #Innovation #TimeWorldsBestCompanies
-
[Team Players] Couper 10 cm de cheveux à la rentrée ? 💇♀️ Défi relevé par les Laboratoires Pierre Fabre au profit de l’association Fake Hair Don't Care. Aux côtés de l’IUCT-Oncopole, 200 coupes seront offertes à nos collaboratrices et collaborateurs, puis transformées en perruques de qualité pour aider les personnes atteintes d’un cancer. 👱♀️ Vous aussi, vous pouvez faire un don. Rendez-vous sur Fake Hair Don't Care pour découvrir comment aider ! 💪 #NewWaysToCare #Dixcmalarentree #Qualitedevie #Cancer #Alopécie #Octobrerose
-
We are delighted to announce Pierre Fabre Laboratories' participation in the #ESMO Annual Meeting 2024 from September 13 to 17 in Barcelona! 📅 Meet us at our booth n°407, immerse yourself in a unique experience and learn more about our oncology portfolio. Our dedicated teams are here to welcome you. 🎤 Join us on September 16 for our symposium "Precision oncology for BRAF mutant cancers” will be chaired by the esteemed Pr. Josep Tabernero and will provide you with insightful presentations and discussions from our expert panel Pr. Chiara Cremolini, Pr. Reinhard Dummer, Pr. Axel Hauschild and Dr. Gregory Riely. 👉 For more information: https://lnkd.in/d6ESFYyS 👉 Stay tuned on Pierre Fabre Oncology to learn more! At Pierre Fabre Laboratories, and more particularly at a congress such as ESMO, our goal is to exchange ideas and forge links with experts in oncology. Our current expertise covers colorectal, breast and lung cancers, melanoma and haematology. We believe that together we can make significant progress towards a better world. #PierreFabre #NewWaysToCare #ESMO24 #Oncology #Innovation